Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-110-1 | CAS number: 68938-03-4 The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Octene, hydroformylation products, low-boiling
- EC Number:
- 273-110-1
- EC Name:
- Octene, hydroformylation products, low-boiling
- Cas Number:
- 68938-03-4
- IUPAC Name:
- Octene, hydroformylation products, low-boiling
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: crl:CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld. Germany
- Age at study initiation: Main Study: 52 - 53 days
Satellite animals: 62 days
- Weight at study initiation: Main Study: 160 - 196 g
Satellite animals: 198 - 227 g
- Assigned to test groups randomly: yes
- Fasting period before study: no
- Housing: Granulated textured wood (Granulat A2, J. Brandenburg, 49424 Goldenstedt, Germany) was used as bedding material for the cages. The cages were changed and cleaned twice a week.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C */- 3°C
- Humidity (%): 55% */- 15%
- Photoperiod (hrs dark / hrs light): The rooms were lit (about 150 lux at approx. 1.50 m room height) and darkened for periods of 12 hours each
IN-LIFE DATES: From: July 05 To: July 14, 2016
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Amount of vehicle (if gavage or dermal): 4 mL/kg b.w. - Frequency of treatment:
- single dose
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- Dose / conc.:
- 2 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- positive reference: cyclophosphamide (CPA)
- Doses / concentrations: 27 mg/kg b.w., i.p.
Examinations
- Tissues and cell types examined:
- Bone marrow cells and plasma cells for toxicokinetics
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The dose levels for the study had been selected in agreement with the Sponsor based on the results of a preliminary dose-range-finding study in rats.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Bone marrow smears were prepared from all treatment groups 24 hours post administration. Additional samples were prepared from the vehicle control and the high dose group 48 hours post administration.
DETAILS OF SLIDE PREPARATION:
Two smears from the bone marrow of 30 to 60 mm length were prepared.
After air drying, the preparations were immediately fixed in methanol for 5 minutes. Immediately after fixation, the cells were stained for 6 minutes using filtered Mayers Haemaleum. The slides were rinsed with cold tap water for 5 minutes and then further stained in 0.5% w/v ethanolic eosin solution for 1 minute. The slides were rinsed again and then left to air-dry before being dipped in xylene and mounted.
METHOD OF ANALYSIS:
Four thousand (4000) polychromatic erythrocytes per animal were scored for the incidence of micronuclei, and the ratio of polychromatic (PCE) to normochromatic erythrocytes (NCE) was determined for each animal by counting a total of 500 erythrocytes. - Evaluation criteria:
- After completion of scoring and decoding of slides, the ratio of PCE/NCE for each animal and the mean for each group was calculated. The individual and group mean frequencies of micronucleated PCE/1000 were also determined.
The test chemical was considered as clearly positive in this assay if
i) - a statistically significant increase in the frequency of micronucleated PCE occurred for at least one dose at one kill time
ii) - the frequency of micronucleated PCE at such a point exceeded the historical control range
iii) - corroborating evidence was obtained, for example, increased but statistically insignificant frequencies or micronucleated PCE at other doses or kill times, or dose response profiles.
Results and discussion
Test results
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): No test item-related increase of micronucleated polychromatic erythrocytes was observed at the two sampling times
- Ratio of PCE/NCE (for Micronucleus assay): Neither the PCE/NCE ratios nor the numbers of micronucleated PCE were influenced up to highest reasonable dose level 2000 mg/kg b.w. The numbers of micronucleated PCE were also similar to those seen in historical controls.
-Toxicokinetik evaluation: The results of the toxicokinetic evaluation confirmed a pronounced exposure of the plasma and in particular of the bone marrow to the test item, the bone marrow being the endpoint in this assay.
- Statistical evaluation: No statistical significance (at p ≤ 0.05) was reached after statistical analysis by chi2 test. In all of the cyclophosphamide-treated rats, the numbers of micronucleated PCE significantly exceeded those seen in the vehicle control groups, such that the group mean frequency (3.4/1000) was approximately 22 times higher than the group mean frequency seen in the concurrent vehicle control.
Applicant's summary and conclusion
- Conclusions:
- In conclusion, under the present test conditions, Oxooil LS9 tested up to the highest reasonable dose level of 2000 mg/kg b.w. following single oral administration showed no genotoxic properties in the rat bone marrow micronucleus test at the two tested sampling times of 24 hours and 48 hours.
The results of the toxicokinetic evaluation confirmed a pronounced exposure of the plasma and in particular of the bone marrow to the test item, the bone marrow being the endpoint in this assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
